Cell Therapy BioCollagen Platform Life Science About RMS News Room IRS Support
Cell Therapy
ADIFORM
DERMAN
BABYCELL
BioCollagen
THERACOL®
RMS BioCollagen™
Liposome™
THERAFILL®
THERAFORM™
NOVOSTRATA
Platform
Platform
Operating Software
Apparatus & Instrument
Life Science
GLP Service
CRO Service
Labware
Regent
About RMS
Overview
Company Background
History
Market
Certificate
Location
Bio-Network
News Room
News Releases
Exhibition Schedule
IRS
About IRS
News & Journals
Member Services
Global Network
Support
Contact
Download
News Releases
TheraForm, received 510(k) clearance from the FDA
Sewon Cellontech has announced that TheraForm™ Standard and Sheet types have been cleared for marketing in the United States of America through the 510(k) Premarket Notification. Theraform is intended for the management of wound d...
Date : Sep 01, 2009
The first RM platform in the Netherlands running smoothly
After successful installing and testing at the first RM platform in the Netherlands, the C-class platform has been running on their own with public reputation of a cutting edge cartilage laboratory in the Gemini Hospital in Den Helder. On September 05, Friday the initiator,...
Date : Sep 08, 2008
RMS spreads into the Middle East, establishing RMS Persia in Iran
Sewon Cellontech has agreed to establish a Joint Venture company called ‘RMS Persia’ with an Iranian company, Irenic Co. (P.J.S). It becomes the first arrangement for RMS to enter the Middle East market as supplying RMS C-class platform to be installed in Iran. Moreover, the...
Date : Jun 18, 2008
Workshop for Chondron® at RNOH in London, UK
With strong business collaboration and support from RNOH (Royal National Orthopaedic Hospital) in London, RMS had a chance to have workshop for orthopaedic surgeons at teaching center located at RNOH on 21st of May by introducing Autologous Chondrocytes Implantation with Cho...
Date : May 21, 2008
Contracted for the first C-class RM platform and UCBSC RM platform in Kazakhstan
Sewon Cellontech has announced that they signed the contract for the supply of C-class RM platform and Umbilical cord blood stem cell RM platform with Beecenter LLP. Beecenter plans to set up C-class RM platform and UCBSC RM platform to produce cartilage, bone and to store u...
Date : May 19, 2008
Signed a License agreement to establish RMS cell processing facility in India
Sewon Cellontech has signed a License agreement with an Indian biotech enterprise, Satyan Interchem Pvt. Ltd. to provide technology license for the fully equipped cell processing facility called RMS H-class platform in Mumbai, India as of April 24, 2008. Through this agreem...
Date : Apr 25, 2008
      1 2 [3] 4 5 6 7